New report digs into Medicare's $200 billion in gross drug expenditures
A return to some drug pricing normalcy
Ben LinkNADAC, Medicaid, Generic, cincacalcet, CBO, Brand drugs, List prices, Rebates, Pfizer, Upjohn, Viatris, Depo-Provera, WAC, Gamunex-C, Part D, ADHD, dexmethylphenidate, Methylphenidate, lamotrigine, Paliperidone, clozapine, tizanidine, dosage forms, polyethylene glycol
Drugmakers break record for most January list price increases in a decade
Ben LinkNADAC, Medicaid, Generic, Semglee, Basaglar, Albendazole, Part D, Eliquis, Grassley, Wyden, Insulin, Mycophenolic Acid, Dalfampridine, clobazam, cincacalcet, Mark Cuban, acetaminophen, lansoprazole ODT, lamotrigine, Clonidine, atomoxetine
